Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Integrated Diagnostics Holdings ( (GB:IDHC) ) is now available.
Integrated Diagnostics Holdings (IDH) announced it will release its unaudited financial results for the quarter and six-month periods ending 30 June 2025 on 2 September 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial health and operational performance across its markets in the Middle East and Africa. The results will be followed by an analyst and investor call, indicating IDH’s commitment to transparency and engagement with its investors.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a prominent diagnostics services provider in the Middle East and Africa, offering a wide range of clinical pathology and radiology tests. Operating in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan, the company boasts over 40 years of experience and a reputation for quality and safety. IDH operates through core brands such as Al Borg, Al Borg Scan, and Al Mokhtabar in Egypt, Biolab in Jordan, Echo-Lab in Nigeria, and others. With a scalable Hub, Spoke, and Spike business model, IDH aims for organic growth and expansion into new markets, leveraging its extensive network of 628 branches that served over 8.9 million patients in 2024.
Average Trading Volume: 533,483
Technical Sentiment Signal: Hold
Current Market Cap: $284.8M
For an in-depth examination of IDHC stock, go to TipRanks’ Overview page.